Thema
Letter
Comment
101
Research Support, Non-U.S. Gov't
15
Case Reports
12
3QKI37EEHE
11
415SHH325A
11
Adenosine Monophosphate
11
Alanine
11
OF5P57N2ZX
11
remdesivir
11
Aerosols
7
Research Support, N.I.H., Extramural
7
2494G1JF75
6
Antibodies, Viral
6
Antiviral Agents
6
Lopinavir
6
O3J8G9O825
6
Ritonavir
6
4QWG6N8QKH
4
Hydroxychloroquine
4
COVID-19 Vaccines
3
Immunoglobulin G
3
Lupus Coagulation Inhibitor
3
RNA, Messenger
3
Viral Vaccines
3
Multicenter Study
2
2-((3-ethyl-5-(2-(3-methylbenzo(d)thiazol-2(3H)-ylidene)ethylidene)-4-oxothiazolidin-2-ylidene)methyl)-5-fluoro-3-methylbenzo(d)thiazol-3-ium
1
Antibodies, Anti-Idiotypic
1
Antibodies, Anticardiolipin
1
Antibodies, Antiphospholipid
1
Anticoagulants
1
Benzothiazoles
1
Biological Products
1
Comparative Study
1
Fibrin Fibrinogen Degradation Products
1
Glucose
1
IY9XDZ35W2
1
Immunoglobulin A
1
Immunosuppressive Agents
1
Interferon Type I
1
Janus Kinase Inhibitors
1
Methylprednisolone
1
Myxovirus Resistance Proteins
1
Prednisone
1
RNA, Viral
1
Research Support, N.I.H., Intramural
1
Retraction of Publication
1
VB0R961HZT
1
X4W7ZR7023
1
fibrin fragment D
1